Medication info
Riseplus Tablet

Riseplus Tablet

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.162mg / 1 tabletCholecalciferol Concentrate Powder›56mg / 1 tablet
Manufacturer / importer
Huons Lifesciences Co., Ltd.
Appearance
Light orange oval film-coated tablet
Packaging
4 tablets (4 tablets/PTP x 1)
Approval status
Active

MFDS item code 201605159 · Approved 2016.08.29 · Insurance code 052700990

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
Adults: Administer 1 tablet of this medicine orally once weekly. Elderly patients: No dose adjustment is necessary in elderly patients (60 years and older), as the bioavailability and pharmacokinetics of this medicine are similar to those in younger people. Patients with renal impairment: No dose adjustment is necessary in patients with a creatinine clearance of 30ml/min or more. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance below 30ml/min. Food interferes with the absorption of this medicine. To ensure adequate absorption, take it as follows. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To help this medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce absorption of this medicine. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should also not lie down for at least 30 minutes after taking it. Patients should take supplements if their dietary intake of calcium and vitamin D is insufficient. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may need additional vitamin D supplements. Patients with gastrointestinal malabsorption syndrome may need higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Once-weekly administration of this medicine provides a week's supply of 800 IU of vitamin D per day. If a patient forgets to take a dose on the scheduled day, take it on the day they remember. Take the next dose again on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
Pediatric patients: The safety and efficacy in children and adolescents during growth have not been established.

Ingredients

Manufacturer
Huons Lifesciences Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

  • Osteoporosis
View approved original text

This medication is used for the treatment and prevention of osteoporosis in both postmenopausal women and men.

How to take

Adult dose

Adults: Administer 1 tablet of this medicine orally once weekly. Elderly patients: No dose adjustment is necessary in elderly patients (60 years and older), as the bioavailability and pharmacokinetics of this medicine are similar to those in younger people. Patients with renal impairment: No dose adjustment is necessary in patients with a creatinine clearance of 30ml/min or more. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance below 30ml/min. Food interferes with the absorption of this medicine. To ensure adequate absorption, take it as follows. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To help this medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce absorption of this medicine. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should also not lie down for at least 30 minutes after taking it. Patients should take supplements if their dietary intake of calcium and vitamin D is insufficient. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may need additional vitamin D supplements. Patients with gastrointestinal malabsorption syndrome may need higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Once-weekly administration of this medicine provides a week's supply of 800 IU of vitamin D per day. If a patient forgets to take a dose on the scheduled day, take it on the day they remember. Take the next dose again on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

Pediatric patients: The safety and efficacy in children and adolescents during growth have not been established.

Precautions

This drug can irritate the stomach and esophagus, which may lead to issues such as esophagitis or esophageal ulcers. It must be taken with a sufficient amount of water after ingestion, and lying down for some time after taking it should be avoided. If difficulty swallowing or symptoms such as chest pain or heartburn occur, discontinue use immediately and consult a doctor. This medication is contraindicated for patients with certain esophageal diseases or severely impaired kidney function. Additionally, it should not be used by individuals who are allergic to any of its ingredients. During treatment, it is advisable not to take other medications or foods containing calcium, magnesium, or iron together with this drug. This medication is used for the treatment of osteoporosis, and supplementation may be necessary if there is an inadequate intake of calcium and vitamin D. If dental treatment is needed, there may be a risk of jaw necrosis, so a consultation with a doctor is essential before treatment. Women who are pregnant or breastfeeding must consult a physician before taking this medication. Elderly individuals can generally use it safely, but they must adhere strictly to the dosing instructions. Overdosage can lead to hypocalcemia, so caution is necessary, and if symptoms appear, medical personnel should be notified immediately. The safety and efficacy of this medication in children have not been established; therefore, it is not used in children. To maximize the drug's efficacy, it is crucial to follow the dosing regimen accurately.

Side effects

  • esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • hemorrhage
  • dysphagia
  • odynophagia
  • retrosternal pain
  • heartburn
Show 118 more
  • gastric ulcer
  • duodenal ulcer
  • infection
  • low back pain
  • pain
  • abdominal pain
  • neck pain
  • weakness
  • chest pain
  • hernia
  • hypertension
  • cardiovascular disease
  • angina
  • nausea
  • diarrhea
  • bloating
  • gastritis
  • gastrointestinal disease
  • rectal disease
  • dental disease
  • petechiae
  • anemia
  • arthralgia
  • joint abnormalities
  • myalgia
  • bone pain
  • bone abnormalities
  • leg cramps
  • synovitis
  • tendon abnormalities
  • depression
  • dizziness
  • insomnia
  • anxiety
  • neuralgia
  • vertigo
  • hypertonia
  • sensory abnormalities
  • pharyngitis
  • rhinitis
  • respiratory distress
  • pneumonia
  • rash
  • pruritus
  • skin cancer
  • cataract
  • conjunctivitis
  • otitis media
  • urinary tract infection
  • cystitis
  • injury due to accident
  • influenza-like illness
  • headache
  • overdose
  • allergic reaction
  • syncope
  • vasodilation
  • constipation
  • dyspepsia
  • nausea
  • gastroenteritis
  • colitis
  • vomiting
  • thirst
  • peripheral edema
  • traumatic fracture
  • arthritis
  • bronchitis
  • sinusitis
  • increased cough
  • fever
  • falling
  • dizziness
  • bronchitis
  • sinusitis
  • increased cough
  • low back pain
  • osteoarthritis
  • limb pain
  • muscle rigidity
  • neck pain
  • weakness
  • fever
  • hypercholesterolemia
  • uveitis
  • iritis
  • osteonecrosis of the jaw
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blister
  • skin reaction
  • external auditory canal osteonecrosis
  • loss of appetite
  • myalgia
  • chest discomfort
  • epigastric pain
  • chest unease
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • fatty liver
  • increased serum alkaline phosphatase
  • facial swelling
  • hair loss
  • olfactory disturbance
  • hypocalcemia
  • hypercalcemia
  • hypercalciuria
  • polyuria
  • polydipsia
  • weakness
  • drowsiness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. Additionally, the drug should be kept at room temperature, not too hot or cold, ideally between 1 degree and 30 degrees.

Appearance and packaging

Appearance

Light orange oval film-coated tablet

Package unit

4 tablets (4 tablets/PTP x 1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.